Skip to main content

Photodynamic Therapy

  • Chapter
  • First Online:
Book cover Skin Cancer Management

Abstract

In general terms, photodynamic therapy (PDT) involves the use of a light source to activate a compound (photosensitizer) within malignant cells. The activated compound then transfers its energy to molecular oxygen, which works in a destructive capacity to eliminate the tumor.1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marcus SL, McIntyre WR. Photodynamic Therapy systems and applications. Expert Opin Emerg Drugs. 2002;7:331–334.

    Article  Google Scholar 

  2. Tierney EP, Eide MJ, Jacobsen G, Ozog D. Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther. 2008;10:81–86.

    Article  PubMed  Google Scholar 

  3. Kaufmann R, Spelman L, Weightman W, Reifenberger J, Szeimies RM, Verhaeghe E, et al. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol. 2008;158:994–999.

    Article  CAS  PubMed  Google Scholar 

  4. Surrenti T, De Angelis L, Di Cesare A, Fargnoli MC, Peris K. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. Eur J Dermatol. 2007;17:412–415.

    CAS  PubMed  Google Scholar 

  5. Levulan Kerastick. FDA Label (NDA 020-965). 2003. http://www.fda.gov/cder/foi/label/1999/20965lbl.pdf. Last accessed February 3, 2009.

  6. Ehrig T, Cockerell C, Piacquadio D, Dromgoole S. Actinic keratoses and the incidence of occult squamous cell carcinoma: a clinical-histopathologic correlation. Dermatol Surg. 2006;32:1261–1265.

    Article  CAS  PubMed  Google Scholar 

  7. METVIXIA (methyl aminolevulinate) Cream, 16.8%. FDA Label. 2007.

    Google Scholar 

  8. Smith S, Piacquadio D, Morhenn V, Atkin D, Fitzpatrick R. Short incubation PDT versus 5-FU in treating actinic keratoses. JDD. 2003;2:629–635.

    PubMed  Google Scholar 

  9. Alexiades-Armenakas M, Geronemus R. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol. 2004;3:548–551.

    PubMed  Google Scholar 

  10. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic Photorejuvenation. Dermatol Surg. 2002;28:742–744.

    Article  CAS  PubMed  Google Scholar 

  11. Karrer S, Baumler W, Abels C. Long-Pulse Dye Laser for Photodynamic therapy: Investigations in Vitro and in Vivo. Lasers Surg Med. 1999;25:51–59.

    Article  CAS  PubMed  Google Scholar 

  12. Morton C, Campbell S, Gurg G. Intraindividual right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol. 2006;155:1029–1036.

    Article  CAS  PubMed  Google Scholar 

  13. United Kingdom Summary of Product Characteristics. 2007. http://www.medicines.org.uk/. Last accessed 1/20/09.

  14. Australia Summary of Product Characteristics. 2007. Australian Regulatory Guidelines for OTC Medicines. http://www.tga.gov.au/docs/html/argom.htm. Last accessed 1/20/09.

  15. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol. 2003;149:1242–1249.

    Article  CAS  PubMed  Google Scholar 

  16. Rhodes LE, de Rie MA, Leifsdottir R, Yu RC, Bachmann I, Goulden V, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol. 2007;143:1131–1136.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are sincerely grateful to Anne Paquette, RN, BSN, CCRC, and Michelle McCarthy, RPA-C, for their assistance in preparing this manuscript.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Zeitouni, N.C., Oseroff, A., Najarian, D.J. (2009). Photodynamic Therapy. In: MacFarlane, D.F. (eds) Skin Cancer Management. Springer, New York, NY. https://doi.org/10.1007/978-0-387-88495-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-88495-0_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-88494-3

  • Online ISBN: 978-0-387-88495-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics